[Congressional Record (Bound Edition), Volume 159 (2013), Part 8]
[Extensions of Remarks]
[Page 10912]
[From the U.S. Government Publishing Office, www.gpo.gov]




             IN RECOGNITION OF SCLERODERMA AWARENESS MONTH

                                 ______
                                 

                           HON. PETER T. KING

                              of new york

                    in the house of representatives

                         Friday, June 28, 2013

  Mr. KING of New York. Mr. Speaker, I rise today in recognition of 
Scleroderma Awareness Month.
  On behalf of the thousands of patients impacted by this disease in my 
district and throughout the State of New York, I am honored to join 
Congresswoman Capps as the lead co-sponsor of H.R. 1429, the 
Scleroderma Research and Awareness Act.
  Research supported by the National Institutes of Health has led to 
groundbreaking discoveries in possible treatments and has enhanced the 
medical community's understanding of the progression of this disease. 
As physicians and medical researchers have yet to find a cure or a 
disease-specific treatment, physicians are left offering treatments 
that minimize the impact of the disease's progression and alleviate 
patient symptoms. This legislation provides for continued federal 
investment at the National Institute of Arthritis, Musculoskeletal and 
Skin diseases in basic and clinical research related to scleroderma.
  I rise today to encourage my colleagues to join us in supporting H.R. 
1429 and to participate in the many scleroderma awareness activities 
organized by patient and community groups in their communities. Please 
join me in supporting the efforts of the 300,000 patients and their 
families to bring awareness to this disease and hopefully, one day a 
cure.

                          ____________________